How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines
oleh: Anna Falanga, Hugo Ten Cate, Bianca Rocca
| Format: | Article |
|---|---|
| Diterbitkan: | PAGEPress Publications 2023-01-01 |
Deskripsi
With ageing of the population, both the risks of cardiovascular disease (CVD) and cancer are increasing worldwide, and the risk factors (e.g. obesity, diabetes) are often shared between the two conditions. Thus, more subjects will also develop the two illnesses concurrently [...].